# PK Study in Patients With Parkinson's Disease With IZD174

> **NCT04338997** · PHASE1 · WITHDRAWN · sponsor: **Inflazome UK Ltd**

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** IZD174

## Key facts

- **NCT ID:** NCT04338997
- **Lead sponsor:** Inflazome UK Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-10
- **Primary completion:** 2020-11
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Strategic decision by Sponsor
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04338997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04338997, "PK Study in Patients With Parkinson's Disease With IZD174". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04338997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*